Cervical cancer screening Conference Paper uri icon


MeSH Major

  • Uterine Cervical Neoplasms


  • Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed. © Journal of the National Comprehensive Cancer Network.

publication date

  • January 2008



  • Conference Paper



  • eng

PubMed ID

  • 18267060

Additional Document Info

start page

  • 58

end page

  • 82


  • 6


  • 1